| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| nd7001 | cgmp-dependent 3',5'-cyclic phosphodiesterase | small molecule | NA | drugbank , DGIDB | Anxiety Disorders[MeSHID:D001008] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mood Disorders[MeSHID:D019964] |
NA | investigational | unknown |
| nd7001 | phosphodiesterase 2a, cgmp-stimulated | small molecule | NA | drugbank , DGIDB | Anxiety Disorders[MeSHID:D001008] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mood Disorders[MeSHID:D019964] |
NA | investigational | unknown |
| nd7001 | phosphodiesterase 2a | NA | Clinical trial target | TTD , DGIDB | Anxiety Disorders[MeSHID:D001008] Mental Depression[MeSHID:D003863] Depressive disorder[MeSHID:D003866] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Mood Disorders[MeSHID:D019964] |
NA | phase 1 | unknown |
| click here to return to the previous page | ||||||||